Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-25-233665
Filing Date
2025-10-07
Accepted
2025-10-07 17:22:29
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d90728d424b3.htm 424B3 33133
2 GRAPHIC g90728g1006233723004.jpg GRAPHIC 3369
  Complete submission text file 0001193125-25-233665.txt   39206
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-284606 | Film No.: 251380665
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)